EQUUS INNOVATIONS
Live / Registered — Registered (as of 15 Sept 2020)
What this means for you
Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was filed 11 Sept 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 88112825
- Registration number
- 6153905
- Mark type
- Word mark
- Kind
- Trademark
- Register
- Principal
- Basis
- Use in commerce (§1(a))
- Filed
- 11 Sept 2018
- Published for opposition
- 17 Sept 2019
- Registered
- 15 Sept 2020
- Next maintenance filing
- §8 declaration of use, filed 11 Sept 2026 — awaiting the USPTO's acceptance
- Examining attorney
- Leslie Richards
- Attorney of record
- Quan Nguyen
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic products, namely, liquid therapeutic preparations derived from amnion and amniotic fluid for internal tissue implantation and for topical treatment to promote healing and rejuvenation of wounds bodily tissue
Owner
- Equistem Technology, LLC, Scottsdale, AZ, US
- Equistem Technology, LLC, Phoenix, AZ, US
- Equistem Technology, LLC, Phoenix, AZ, US
Prosecution history
- 16 Nov 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Sept 2026 — TEAS SECTION 8 & 15 RECEIVED
- 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 12 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Aug 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Aug 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Jul 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 May 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 May 2020 — NON-FINAL ACTION E-MAILED
- 30 May 2020 — SU - NON-FINAL ACTION - WRITTEN
- 08 May 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Apr 2020 — USE AMENDMENT FILED
- 08 May 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL